Preclinical/company pr/Kriya Therapeutics

KRIYA-839 gene therapy

Preclinical means it has not yet been tested in humans. It is tracked here as an early pipeline signal, clearly labeled as not yet clinical.

How it works

A gene therapy program aiming to restore insulin production or immune balance through a single treatment. Still in preclinical development.

Approach

One-time gene therapy

Immunosuppression

Not applicable (preclinical)

Live trial status

No registered clinical trial is tracked for this program yet (it may be preclinical or early). See the official program links for the latest.

These are research programs pursuing a functional cure or disease modification for type 1 diabetes. None is a confirmed, broadly available cure. Trial status is informational, not medical advice, and not a recruiting offer. Verify eligibility and details with the official trial record and a clinician.

Family-tested T1D gear

Some links below are affiliate links. If you buy through them, Type1Cure may earn a small commission at no extra cost to you. Affiliate relationships never affect our research coverage, evidence labels, rankings, or safety alerts.

Daily gearCGM adhesive patchesKeep sensors on through sports, showers, and sweat. A daily-life staple for T1D families.Daily gearInsulated diabetes travel caseOrganize insulin, supplies, and a backup kit for school, travel, and emergencies.LowsFast-acting glucose tabletsA reliable low-treatment to keep in every bag, locker, and nightstand.LearningBooks on living with type 1Guides for newly-diagnosed families, teens, and caregivers learning the ropes.